BackNavicare Biotech , Ltd. Overview

Navicare Biotech , Ltd. Current Assets

Latest current assets for 8472.TWO: $320M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$318.23M
↓ 10.48% YoYΔ $-37.26M vs prior year quarter

Peer trimmed avg / median

Loading

Navicare Biotech , Ltd. Current Assets History

Loading

Navicare Biotech , Ltd. vs. peers: Current Assets Comparison

Loading

Navicare Biotech , Ltd. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Navicare Biotech , Ltd. (8472.TWO) FAQ

As of the most recent data (June 2026), 8472.TWO shows a current assets of $320M. That compares with $360M in the prior-year period — down 10.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 8472.TWO's current assets is now $320M (was $360M) — a 10.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Navicare Biotech , Ltd. is outperforming or lagging.

Tracking 8472.TWO's current assets over time shows whether Navicare Biotech , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $320M That compares with $360M in the prior-year period — down 10.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Navicare Biotech , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $320M) with ownership activity and broader fundamentals.